LEADER 03319nam  22006015  450 
001 9910300357303321
005 20200701043344.0
010   $a3-642-54350-2
024 7 $a10.1007/978-3-642-54350-0
035   $a(CKB)3710000000118082
035   $a(EBL)1731259
035   $a(OCoLC)884014008
035   $a(SSID)ssj0001243626
035   $a(PQKBManifestationID)11808284
035   $a(PQKBTitleCode)TC0001243626
035   $a(PQKBWorkID)11284733
035   $a(PQKB)11166731
035   $a(MiAaPQ)EBC1731259
035   $a(DE-He213)978-3-642-54350-0
035   $a(PPN)178779261
035   $a(EXLCZ)993710000000118082
100   $a20140523d2014      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aImmune Modulation and Anti-Inflammatory Therapy in Ocular Disorders$b[electronic resource] $eIOIS Guidelines /$fedited by Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao
205   $a1st ed. 2014.
210  1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2014.
215   $a1 online resource (253 p.)
300   $aDescription based upon print version of record.
311   $a3-642-54349-9 
320   $aIncludes bibliographical references at the end of each chapters.
327   $aBasics -- Anterior Segment: Specific Disorders -- Post-Surgical Therapy -- Intraocular Inflammation.
330   $aThese guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence, and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject.
606   $aOphthalmology
606   $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004
615  0$aOphthalmology.
615 14$aOphthalmology.
676   $a610
676   $a617.7
676   $a617.7/1
676   $a617.76
702   $aPleyer$b Uwe$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aAlió$b Jorge L$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBarisani-Asenbauer$b Talin$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aLe Hoang$b Phuc$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aRao$b Narsing A$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300357303321
996   $aImmune Modulation and Anti-Inflammatory Therapy in Ocular Disorders$91521770
997   $aUNINA